Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2009-03-30
2010-11-09
Henley, III, Raymond J (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S560000, C514S561000
Reexamination Certificate
active
07829593
ABSTRACT:
The present invention provides a glutamine-containing composition which functions to increase blood flow. Glutamine is present in the composition in an amount of 25 mg/kg body weight to 150 mg/kg body weight. By administering the composition to a subject in need thereof, the blood flow in the capillary vessels can be efficiently increased, while inhibiting any side effects such as low blood pressure. The present invention also provides food or feed containing the composition for increasing blood flow.
REFERENCES:
patent: 5134125 (1992-07-01), Hara et al.
patent: 5248697 (1993-09-01), Wilmore
patent: 5658895 (1997-08-01), Aoi et al.
patent: 6001878 (1999-12-01), Van Leeuwen et al.
patent: 6291525 (2001-09-01), Nissen
patent: 6346264 (2002-02-01), White
patent: 2002/0182162 (2002-12-01), Shahinpoor et al.
patent: 2003/0018076 (2003-01-01), Fossel
patent: 2006/0228396 (2006-10-01), Ohta et al.
patent: 2007/0197392 (2007-08-01), Takeuchi et al.
patent: 08-198748 (1996-08-01), None
patent: 09-241156 (1997-09-01), None
patent: 11-130669 (1999-05-01), None
patent: 2001-316256 (2001-11-01), None
patent: 2002-045122 (2002-02-01), None
patent: 2002-255827 (2002-09-01), None
patent: 2004-018483 (2004-01-01), None
patent: 2004-262878 (2004-09-01), None
patent: 2006-306865 (2006-11-01), None
patent: WO95/18608 (1995-07-01), None
patent: WO02/062329 (2002-08-01), None
Bergana, M. M., et al., “NMR and MS Analysis of Decomposition Compounds Produced from N-Acetyl-L-glutamine at Low pH,” J. Agric. Food Chem. 2000;48:6003-6010.
Biomedical Gerontology 2001;25(2):83-88.
Bode-Böger, S. M., et al., “L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship,” Br. J. Clin. Pharmacol. 1998;46:489-497.
Flynn, W. J., et al., “Intestinal Blood Flow is Restored with Glutamine or Glucose Suffusion after Hemorrhage,” J. Surg. Res. 1992;52:499-504.
Folia Pharmacologica Japonica 2002;119:7-14.
Houdijk, A. P. J., et al., “Clutamine-enriched enteral diet increases splanchnic blood flow in the rat,” Am. J. Physiol. Gastrointest. Liver Physiol. 1994;267:G1035-1040, with Abstract.
McPherson, R. W., et al., “Cerebral Blood Flow in Primates Is Increased by Isoflurame over Time and Is Decreased by Nitric Oxide Synthase Inhibition,” Anesthesiology 1994;80:1320-1327.
Morikawa, E., et al., “L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebal blood flow, and reduces infarction volume in the rat,” Stroke 1994;25:429-435 (Abstract Only).
Pang, K. S., et al., “The Effect of Hepatic Blood Flow on Formation of Metabolites,” Drug Metabolism and Disposition 1990;18(3):270-275.
Roth, E., “L-arginine-nitric oxide metabolism. Glutamine: a new player in this metabolic game?” Clin. Nutr. 1998;17:1-2.
Yarnitsky, D., et al., “Blood-brain barrier opened by stimulation of the parasympathetic sphenopalatine ganglion: a new method for macromolecule delivery to the brain,” J. Neurosurg. 2004; 101:303-309.
International Search Report and Written Opinion of the International Searching Authority for PCT Patent App. No. PCT/JP2007/068988 (Dec. 11, 2007).
Ohta Fumio
Sato Hiroyuki
Takagi Tomo
Ajinomoto Co. Inc.
Cermak Shelly Guest
Cermak Nakajima LLP
Henley, III Raymond J
LandOfFree
Glutamine-containing compositions and a method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glutamine-containing compositions and a method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glutamine-containing compositions and a method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4234903